Skip to content

An Evaluation of the Effectiveness of a Simple Marketing Intervention in Changing Student Attitudes to Depression

A Cluster Randomised Controlled Trial to Assess the Effectiveness of a Simple Marketing Intervention in Changing Student Attitudes to Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00122083
Enrollment
1680
Registered
2005-07-21
Start date
2004-04-30
Completion date
2004-06-30
Last updated
2005-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Depression, Students, Health education

Brief summary

The purpose of this study is to determine the effectiveness of a simple marketing intervention in changing attitudes towards depression and its treatment among university students.

Detailed description

Depression is a major public health problem. It is common, affecting approximately 10 percent of the United Kingdom (UK) community at any one time. Britain's student population is particularly at risk. Knowledge of effective treatments for depression is burgeoning thanks to a rapid increase in the quantity and quality of relevant research. Regardless of these advances, depression is still under-reported (Freeling et al., 1985) and general practitioners often fail to diagnose it. When depression is correctly diagnosed, most patients in primary care will receive a prescription for an antidepressant. However, some patients will not have the prescription dispensed, and most will not complete the full recommended course. Compliance with psychological treatments is also a problem. Study Design: * Pilot work: The intervention consisted of mailing (to each undergraduate student's pigeon-hole) a pack of 4 postcards which provided brief information on depression in an attractive format. One postcard summarised information on depression as an illness; one summarised information on the causes of depression; one summarised information on the treatment of depression; and one summarised information on how to seek help for depression. Prior to the trial, the drafts were revised through feedback from a focus group of 5 students, who discussed the design and content of the draft postcards. The focus group participants were recruited from the Queen's College, as this college did not participate in the trial. The focus group contributed to the revision of the draft questionnaire. * The trial: The design was a cluster, randomised, controlled trial. Individual Oxford University colleges which accept undergraduate students were the units of randomisation. Twenty-eight colleges were randomised. Permanent private halls and postgraduate colleges were excluded, as was the Queen's College (due to it being the lead investigator's college) and Harris Manchester College (a college for mature students). Half of the randomised colleges received no intervention; the other half received the intervention. A questionnaire was administered before and after the intervention to half of the undergraduate students in each of the colleges. The same questionnaire was used for both time points. Questions addressed knowledge of, and attitudes towards: * depression as an illness; * symptoms of depression; * treatment for depression; * sources of help for depression.

Interventions

DEVICEHealth education information

Sponsors

Pfizer
CollaboratorINDUSTRY
Wyeth is now a wholly owned subsidiary of Pfizer
CollaboratorINDUSTRY
University of Oxford
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
ECT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Undergraduate students at Oxford University

Exclusion criteria

* Postgraduate students * Students at the excluded colleges

Design outcomes

Primary

MeasureTime frame
The primary outcome was the proportion of participants responding positively to the question 'Can depression be effectively treated?'

Secondary

MeasureTime frame
Secondary outcomes included the correct identification of the symptoms of depression and the effectiveness of certain treatments.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026